Product logins

Find logins to all Clarivate products below.


: Cortellis Deals Intelligence

Here you will find relevant articles and insight into all Clarivate related products and news.

Biopharma mega mergers remain a force: Q1 analysis Biopharma mega mergers remain a force: Q1 analysis
Blog June 19, 2019
Biopharma mega mergers remain a force: Q1 analysis
Biopharma Business Development Cortellis Competitive Intelligence
Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Biopharma Bioworld Business Development
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Biopharma Bioworld Business Development
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Biopharma Bioworld Business Development
Blog September 24, 2018
Key Q2 partnerships driving biopharma
APAC Asia Biopharma
Blog September 11, 2018
Life sciences M&As in the second quarter of 2018: notes, trends and a closer look at APAC
APAC Biopharma Cortellis
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Biopharma deals Bioworld Cortellis
Blog February 22, 2018
Cancer, neurology, immune therapies drive continued robust pace of biopharma financings
Bioworld Cortellis Cortellis Deals Intelligence

Cortellis Deals Intelligence

온디맨드 웨비나 사이트런칭 온디맨드 웨비나 사이트런칭
Blog March 15, 2022
온디맨드 웨비나 사이트런칭
Biopharma mega mergers remain a force: Q1 analysis Biopharma mega mergers remain a force: Q1 analysis
Blog June 19, 2019
Biopharma mega mergers remain a force: Q1 analysis
Blog March 14, 2019
Busy biopharma M&A activity closed out 2018
Blog March 7, 2019
Biopharma licensing finished with a strong Q4
Blog January 24, 2019
Biopharma M&A engine fires up as new year rings in big deals
Blog September 24, 2018
Key Q2 partnerships driving biopharma
Blog September 11, 2018
Life sciences M&As in the second quarter of 2018: notes, trends and a closer look at APAC
Blog May 22, 2018
As we head to BIO International 2018, a look at the changing landscape of biopharma dealmaking
Blog February 22, 2018
Cancer, neurology, immune therapies drive continued robust pace of biopharma financings
Blog February 15, 2018
Life sciences M&A deals in the fourth quarter of 2017: updates and trends